Why Drugs Get Delayed: Blame It On Safety Concerns, Researchers Say
This article was originally published in The Pink Sheet Daily
Executive Summary
However, FDA allows manufacturers more leeway in providing additional data or new analyses to better understand a safety issue than an efficacy concern, according to a Health Affairs study of novel drugs approved after multi-cycle reviews.